CN107683997A - It is a kind of that there is the solid beverage and its preparation technology for improving nerve cell function - Google Patents
It is a kind of that there is the solid beverage and its preparation technology for improving nerve cell function Download PDFInfo
- Publication number
- CN107683997A CN107683997A CN201710631276.3A CN201710631276A CN107683997A CN 107683997 A CN107683997 A CN 107683997A CN 201710631276 A CN201710631276 A CN 201710631276A CN 107683997 A CN107683997 A CN 107683997A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- cell function
- nerve cell
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002569 neuron Anatomy 0.000 title claims abstract description 28
- 235000013361 beverage Nutrition 0.000 title claims abstract description 27
- 230000003915 cell function Effects 0.000 title claims abstract description 27
- 239000007787 solid Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000005516 engineering process Methods 0.000 title claims description 15
- 239000000843 powder Substances 0.000 claims abstract description 84
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 45
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 36
- 240000007154 Coffea arabica Species 0.000 claims abstract description 27
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 23
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 23
- 235000016213 coffee Nutrition 0.000 claims abstract description 23
- 235000013353 coffee beverage Nutrition 0.000 claims abstract description 23
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 22
- 235000013976 turmeric Nutrition 0.000 claims abstract description 22
- 235000005340 Asparagus officinalis Nutrition 0.000 claims abstract description 21
- 235000021028 berry Nutrition 0.000 claims abstract description 21
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 20
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 20
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 20
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 20
- 235000020232 peanut Nutrition 0.000 claims abstract description 20
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 18
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 18
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 18
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 18
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 17
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920001202 Inulin Polymers 0.000 claims abstract description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 16
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 16
- 229940029339 inulin Drugs 0.000 claims abstract description 16
- 239000000832 lactitol Substances 0.000 claims abstract description 16
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims abstract description 16
- 229960003451 lactitol Drugs 0.000 claims abstract description 16
- 235000010448 lactitol Nutrition 0.000 claims abstract description 16
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000013078 crystal Substances 0.000 claims abstract description 15
- 244000003416 Asparagus officinalis Species 0.000 claims abstract 6
- 239000011812 mixed powder Substances 0.000 claims description 24
- 230000033001 locomotion Effects 0.000 claims description 12
- 238000007873 sieving Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 6
- 238000010348 incorporation Methods 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 239000000565 sealant Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 235000007460 Coffea arabica Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 241000505673 Scintilla Species 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims 1
- 235000017491 Bambusa tulda Nutrition 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims 1
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 235000006886 Zingiber officinale Nutrition 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 239000011425 bamboo Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 235000008397 ginger Nutrition 0.000 claims 1
- 238000005286 illumination Methods 0.000 claims 1
- 125000001095 phosphatidyl group Chemical group 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 230000003068 static effect Effects 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 abstract description 8
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 abstract description 8
- 230000032683 aging Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 150000008106 phosphatidylserines Chemical class 0.000 abstract 1
- 241000234427 Asparagus Species 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 210000004556 brain Anatomy 0.000 description 12
- 210000005036 nerve Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000015654 memory Effects 0.000 description 5
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000001073 episodic memory Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000001259 mesencephalon Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000897 modulatory effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001730 monoaminergic effect Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001769 parahippocampal gyrus Anatomy 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of solid beverage for having and improving nerve cell function, including following component：Oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder, lactitol, circle luxuriant Cillium, wolfberry fruit powder, turmeric, coffee certain kind of berries fruit powder, gamma aminobutyric acid and phosphatidyl serine.Food and Chinese medicine and modern biotechnology class preparation crystal diabetin, the gamma aminobutyric acid and phosphatidyl serines such as traditional asparagus powder, peanut powder, oatmeal, wolfberry fruit powder, turmeric, the luxuriant Cillium of circle and coffee certain kind of berries fruit powder are used in combination with the present invention, to lifting the BDNF concentration in human body, improve the health and organism aging process problem significant effect of the elderly.
Description
Technical field
The present invention relates to solid beverage technical field, more particularly to a kind of solid beverage with improvement nerve cell function
And its preparation technology.
Background technology
By the end of the year 2014, more than the 60 years old elderly population in China have reached 2.12 hundred million, account for the 15.5% of total population.According to pre-
Survey, the middle of this century elderly population quantity is up to peak value, more than 400,000,000, just has a elderly in every 3 people at that time.Population
Aging varies widely spectrum of disease, and about 80% elderly population at least suffer from a kind of chronic disease, and this causes them
It is more fragile than Healthy People.4 are respiratory disease, cranial vascular disease, malignant tumour successively before China's the elderly's Proportional Death Rate
And heart disease.In addition, also serious threat the health of the elderly to the disease such as circulation system disease, diabetes, senile dementia.
It is that the nerve that content is most abundant in brain nourishes the factor that brain source nerve, which nourishes the factor (BDNF), and it adjusts nerve and passed
Lead, neure growth, the process of differentiation and remodeling (such as hippocampal gyrus administered memory and study).Many non-neuronal cells groups
Knit and cell can break up BDNF acceptors, concentration reduces with the age in vivo for it, and its concentration has with many health and problem of aging
Close.Therefore BDNF concentration can be effectively improved neurogenic disease and metabolic syndrome in lifting body.Turmeric, coffee certain kind of berries fruit can be significantly
Increase blood plasma midbrain source nerve and nourish the factor (BDNF).
The invention provides a kind of solid beverage and its preparation technology for having and improving nerve cell function, people can be lifted
Internal BDNF concentration, improve the health and organism aging process problem of the elderly.
The content of the invention
Based on technical problem existing for background technology, the present invention proposes a kind of solid for having and improving nerve cell function
Beverage and its preparation technology.
Technical scheme is as follows：
It is a kind of have improve nerve cell function solid beverage, including following weight than composition：Oatmeal 10-30
Part, crystal diabetin 10-30 parts, inulin 10-30 parts, peanut powder 10-30 parts, asparagus powder 5-10 parts, lactitol 5-10 parts, the luxuriant car of circle
Preceding sub- shell powder 1-10 parts, wolfberry fruit powder 1-10 parts, turmeric 0.1-1 parts, coffee certain kind of berries fruit powder 0.1-1 parts, γ-aminobutyric acid 0.1-1 parts,
Phosphatidyl serine 0.1-1 parts.
Preferred compositions scheme provided by the invention is：24.4 parts of oatmeal, 18 parts of crystal diabetin, 15 parts of inulin, peanut powder
15 parts, 10 parts of asparagus powder, 10 parts of lactitol, luxuriant 5 parts of the Cillium of circle, 2 parts of wolfberry fruit powder, 0.3 part of turmeric, coffee certain kind of berries fruit powder
0.1 part, 0.1 part of γ-aminobutyric acid, 0.1 part of phosphatidyl serine.
Preferably, the asparagus powder selected by the present invention is asparagus juice extraction concentration powder【The patent No.
ZL201110278589.8】, cortisol levels can be effectively reduced, serotonin secretion are improved, so as to improve sleep quality.【S
Krishnamurthy,D Garabadu,NR Reddy.modulates the hypothalamic–pituitary–
adrenal axis and brain monoaminergic systems in rats[J].《Nutritional
Neuroscience》,2013,16(6):255-261】
Preferably, the coffee certain kind of berries fruit powder selected by the present invention is the full fruit of ripe arabica coffees (including exocarp, fruit
Meat, fruit stone) the full fruit concentration powder of the coffee that is obtained through water extraction【US 7754263】, it is complete to preserve high antioxygen contained in coffee drupe
Chemical conversion point, blood plasma midbrain source nerve can be dramatically increased and nourish the factor.【T Reyesizquierdo, B Nemzer, CShu, L
Huynh, R Argumedo, Modulatory effect of coffee fruit extract on plasma levels
of brain-derived neurotrophic factor in healthy subjects[J].《British Journal
of Nutrition》,2013,110(3):1-6】
Preferably, the turmeric selected by the present invention is scintilla turmeric, and it is water-soluble, dispersed to significantly improve common turmeric
The problem of difference, metabolism are fast, and human body utilization rate is low.It can cross-domain blood-brain barrier, directly act on Beta amyloid
(Amyloid) and promote brain source nerve to nourish factor generation, have positive role to preventing and improving brain memory decay disease.
Preferably, the peanut powder specification selected by the present invention is the following peanut powder of 40 mesh.The lecithin contained in fruit
And cephalin, it is the important substance required for nervous system, brain function decline can be delayed, suppresses platelet aggregation, prevent brain blood
Bolt is formed.
γ-aminobutyric acid is inhibitory neurotransmitter critically important in central nervous system, is a kind of naturally occurring non-
Protein groups have extremely important physiological function, it can promote the reactivity of brain, brain tonic and intelligence development, anti-epileptic, promote into amino acid
Sleep, beauty moisturizing, delays brain aging function, can supplement human body inhibitory neurotransmitter.The present invention from content 20% γ-
Aminobutyric acid is as raw material.
Preferably, phosphatidyl serine is extracted by crude soya bean oil expression residue, is the active material of cell membrane, is especially deposited
In brain cell.Its function mainly improves nerve cell function, adjusts the conduction of nerve impulse, promotes brain memory work(
Can, because it has very strong lipophilicity, blood-brain barrier can be run through after absorption and enters brain, plays vascular smooth of releiving
Myocyte, increase the effect of brain blood supply.The product of content 50% selected by the present invention is as raw material.
A kind of preparation technology with the solid beverage for improving nerve cell function, comprises the following steps：
A, by γ-aminobutyric acid, the luxuriant Cillium of circle, turmeric, wolfberry fruit powder, phosphatidyl serine and coffee certain kind of berries fruit powder point
Do not crush, the sieving of 40 mesh, be uniformly mixed according to a ratio, obtain mixed powder 1；
B, oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder and lactitol are crushed respectively, 40 mesh sieving, by with
Than being well mixed, mixed powder 2 is obtained；
C, mixed powder 1 and mixed powder 2 are poured into three-dimensional motion mixer always to mix, the rotating speed of described three-dimensional motion mixer
For 10-20r/min, incorporation time 25-35min；
D, dispensed using composite film packaging machine, detect sealant and device；
E, product is subjected to outer packing, finished product storage after quality inspection is qualified, you can.
Preferably, described step A-D is completed in for 100000 grades of clean areas.
Preferably, 100000 grades of described clean areas, specific implementation requirement are：
The present invention is to product quality requirement：
| Project | Index |
| Moisture, g/100g≤ | 7.0 |
| Lead (in terms of Pb), mg/kg≤ | 0.8 |
| Total arsenic (in terms of As), mg/kg≤ | 0.5 |
| Total plate count, CFU/g≤ | 1000 |
| Coliform, MPN/100g≤ | 40 |
| Mould, CFU/g≤ | 50 |
| Pathogenic bacteria (staphylococcus aureus, salmonella, Shigella) | It must not detect |
The present invention is advantageous in that：The present invention's has the solid beverage for improving nerve cell function, including following
Composition：Oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder, lactitol, the luxuriant Cillium of circle, wolfberry fruit powder, turmeric, coffee
Coffee certain kind of berries fruit powder, γ-aminobutyric acid and phosphatidyl serine.By traditional asparagus powder, peanut powder, oatmeal, matrimony vine in the present invention
Food and Chinese medicine and modern biotechnology class preparation crystal diabetin, the γ-ammonia such as powder, turmeric, the luxuriant Cillium of circle and coffee certain kind of berries fruit powder
Base butyric acid and phosphatidyl serine are used in combination with, and to lifting the BDNF concentration in human body, improve the health and machine of the elderly
Body problem of aging significant effect.
Brief description of the drawings
Fig. 1：Mouse active avoidance Experimental comparison's test result figure.
Embodiment
Embodiment 1：
It is a kind of have improve nerve cell function solid beverage, including following weight than composition：24.4 parts of oatmeal,
18 parts of crystal diabetin, 15 parts of inulin, 15 parts of peanut powder, 10 parts of asparagus powder, 10 parts of lactitol, luxuriant 5 parts of the Cillium of circle, matrimony vine
2 parts of powder, 0.3 part of turmeric, 0.1 part of coffee certain kind of berries fruit powder, 0.1 part of γ-aminobutyric acid, 0.1 part of phosphatidyl serine.
A kind of preparation technology with the solid beverage for improving nerve cell function, comprises the following steps：
A, by γ-aminobutyric acid, the luxuriant Cillium of circle, turmeric, wolfberry fruit powder, phosphatidyl serine and coffee certain kind of berries fruit powder point
Do not crush, the sieving of 40 mesh, be uniformly mixed according to a ratio, obtain mixed powder 1；
B, oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder and lactitol are crushed respectively, 40 mesh sieving, by with
Than being well mixed, mixed powder 2 is obtained；
C, mixed powder 1 and mixed powder 2 are poured into three-dimensional motion mixer always to mix, the rotating speed of described three-dimensional motion mixer
For 15r/min, incorporation time 30min；
D, dispensed using composite film packaging machine, detect sealant and device；
E, product is subjected to outer packing, finished product storage after quality inspection is qualified, you can.
Described step A-D is completed in for 100000 grades of clean areas.
Embodiment 2：
It is a kind of have improve nerve cell function solid beverage, including following weight than composition：30 parts of oatmeal, knot
Brilliant 10 parts of fructose, 30 parts of inulin, 10 parts of peanut powder, 10 parts of asparagus powder, 5 parts of lactitol, luxuriant 10 parts of the Cillium of circle, wolfberry fruit powder
1 part, 1 part of turmeric, 0.1 part of coffee certain kind of berries fruit powder, 1 part of γ-aminobutyric acid, 0.1 part of phosphatidyl serine.
A kind of preparation technology with the solid beverage for improving nerve cell function, comprises the following steps：
A, by γ-aminobutyric acid, the luxuriant Cillium of circle, turmeric, wolfberry fruit powder, phosphatidyl serine and coffee certain kind of berries fruit powder point
Do not crush, the sieving of 40 mesh, be uniformly mixed according to a ratio, obtain mixed powder 1；
B, oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder and lactitol are crushed respectively, 40 mesh sieving, by with
Than being well mixed, mixed powder 2 is obtained；
C, mixed powder 1 and mixed powder 2 are poured into three-dimensional motion mixer always to mix, the rotating speed of described three-dimensional motion mixer
For 20r/min, incorporation time 25min；
D, dispensed using composite film packaging machine, detect sealant and device；
E, product is subjected to outer packing, finished product storage after quality inspection is qualified, you can.
Described step A-D is completed in for 100000 grades of clean areas.
Embodiment 3：
It is a kind of have improve nerve cell function solid beverage, including following weight than composition：10 parts of oatmeal, knot
Brilliant 30 parts of fructose, 10 parts of inulin, 30 parts of peanut powder, 5 parts of asparagus powder, 10 parts of lactitol, luxuriant 1 part of the Cillium of circle, wolfberry fruit powder
10 parts, 0.1 part of turmeric, 1 part of coffee certain kind of berries fruit powder, 0.1 part of γ-aminobutyric acid, 1 part of phosphatidyl serine.
A kind of preparation technology with the solid beverage for improving nerve cell function, comprises the following steps：
A, by γ-aminobutyric acid, the luxuriant Cillium of circle, turmeric, wolfberry fruit powder, phosphatidyl serine and coffee certain kind of berries fruit powder point
Do not crush, the sieving of 40 mesh, be uniformly mixed according to a ratio, obtain mixed powder 1；
B, oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder and lactitol are crushed respectively, 40 mesh sieving, by with
Than being well mixed, mixed powder 2 is obtained；
C, mixed powder 1 and mixed powder 2 are poured into three-dimensional motion mixer always to mix, the rotating speed of described three-dimensional motion mixer
For 10r/min, incorporation time 35min；
D, dispensed using composite film packaging machine, detect sealant and device；
E, product is subjected to outer packing, finished product storage after quality inspection is qualified, you can.
Described step A-D is completed in for 100000 grades of clean areas.
Embodiment 4：
It is a kind of have improve nerve cell function solid beverage, including following weight than composition：28 parts of oatmeal, knot
Brilliant 15 parts of fructose, 18 parts of inulin, 20 parts of peanut powder, 8 parts of asparagus powder, 8 parts of lactitol, luxuriant 16 parts of the Cillium of circle, wolfberry fruit powder 4
Part, 0.8 part of turmeric, 0.3 part of coffee certain kind of berries fruit powder, 0.5 part of γ-aminobutyric acid, 0.4 part of phosphatidyl serine.
A kind of preparation technology with the solid beverage for improving nerve cell function, comprises the following steps：
A, by γ-aminobutyric acid, the luxuriant Cillium of circle, turmeric, wolfberry fruit powder, phosphatidyl serine and coffee certain kind of berries fruit powder point
Do not crush, the sieving of 40 mesh, be uniformly mixed according to a ratio, obtain mixed powder 1；
B, oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder and lactitol are crushed respectively, 40 mesh sieving, by with
Than being well mixed, mixed powder 2 is obtained；
C, mixed powder 1 and mixed powder 2 are poured into three-dimensional motion mixer always to mix, the rotating speed of described three-dimensional motion mixer
For 14r/min, incorporation time 29min；
D, dispensed using composite film packaging machine, detect sealant and device；
E, product is subjected to outer packing, finished product storage after quality inspection is qualified, you can.
Described step A-D is completed in for 100000 grades of clean areas.
The sample of embodiment 1 is tested below.
Experiment one, the experiment of mouse active avoidance
Experimental facilities：Shuttle avoidance test case
Preparatory work of experiment
Prepare 20 mouse, be randomly divided into 4 groups, experimental group and each two groups of control group, experimental group gives injected sample, control
Group gives injecting normal saline, and after continuing 5 days, experimental group and control group all inject hyoscyamine and physiological saline respectively, 20 minutes
After carry out avoidance test.
Stimulating exercise：
(1) mouse is put into camera-lucida, after 10s, the door between light and shade case opened.The mouse of most strains has very strong spy
Study carefully behavior, like dark evil light.Therefore, mouse can enter camera bellows quickly.
(2) after mouse (four limbs) is completely into camera bellows, middle door is shut immediately, and give and once shock by electricity.Electric shock intensity be
Mouse can be caused to shrink back the minimum current with sounding.It is different according to mouse species, current range be 0.2~0.8mA (100V, 50
~60Hz AC), continue 1~2s.
(3) allow mouse to stop 10s (so as to allowing animal to form associating between case and electric shock) in camera bellows, mouse is put back to
In cage.Clean operation case.Carry out the training of next animal.
Memory keeps test：After electro photoluminescence is trained 24 hours, one week, mouse is put back into camera-lucida, middle door is opened, but not to electricity
Hit, statistics mouse delay.
Table 1：Mouse active avoidance Experimental comparison's test result
From two groups of parallel laboratory tests, 24h test experiments experimental group contrast control group episodic memory extends respectively
34.42%th, 17.89%, test experiments experimental group contrast control group episodic memory extends 52.46%, 16.02% respectively within 1 week, in fact
Apply the product of example 1 has certain effect to enhancing memory, and amnesia significant effect is more than normal to caused by delaying neurotrosis
Amnesia.
The foregoing is only a preferred embodiment of the present invention, but protection scope of the present invention be not limited thereto,
Any one skilled in the art the invention discloses technical scope in, technique according to the invention scheme and its
Inventive concept is subject to equivalent substitution or change, should all be included within the scope of the present invention.
Claims (9)
1. it is a kind of have improve nerve cell function solid beverage, it is characterised in that including following weight than composition：Oat
Powder 10-30 parts, crystal diabetin 10-30 parts, inulin 10-30 parts, peanut powder 10-30 parts, asparagus powder 5-10 parts, lactitol 5-10
Part, the luxuriant Cillium 1-10 parts of circle, wolfberry fruit powder 1-10 parts, turmeric 0.1-1 parts, coffee certain kind of berries fruit powder 0.1-1 parts, gamma-amino fourth
Sour 0.1-1 parts, phosphatidyl serine 0.1-1 parts.
2. as claimed in claim 1 have the solid beverage for improving nerve cell function, it is characterised in that including following weight
The composition of ratio：24.4 parts of oatmeal, 18 parts of crystal diabetin, 15 parts of inulin, 15 parts of peanut powder, 10 parts of asparagus powder, 10 parts of lactitol,
Luxuriant 5 parts of the Cillium of circle, 2 parts of wolfberry fruit powder, 0.3 part of turmeric, 0.1 part of coffee certain kind of berries fruit powder, 0.1 part of γ-aminobutyric acid, phosphatidyl
0.1 part of serine.
3. as claimed in claim 1 or 2 have the solid beverage for improving nerve cell function, it is characterised in that described reed
Bamboo shoot powder is asparagus juice extraction concentration powder.
4. as claimed in claim 1 or 2 have the solid beverage for improving nerve cell function, it is characterised in that described coffee
Coffee certain kind of berries fruit powder is that the full fruit of coffee that the full fruit of ripe arabica coffees obtains through water extraction concentrates powder.
5. as claimed in claim 1 or 2 have the solid beverage for improving nerve cell function, it is characterised in that described ginger
Huang is scintilla turmeric.
6. as claimed in claim 1 or 2 have the solid beverage for improving nerve cell function, it is characterised in that described phosphorus
Ester acyl serine is by crude soya bean oil expression residue extraction, and the product of the content 50% selected by the present invention is as raw material.
7. a kind of preparation technology with the solid beverage for improving nerve cell function, it is characterised in that comprise the following steps：
A, γ-aminobutyric acid, the luxuriant Cillium of circle, turmeric, wolfberry fruit powder, phosphatidyl serine and coffee certain kind of berries fruit powder are distinguished into powder
It is broken, the sieving of 40 mesh, it is uniformly mixed according to a ratio, obtains mixed powder 1；
B, oatmeal, crystal diabetin, inulin, peanut powder, asparagus powder and lactitol are crushed respectively, the sieving of 40 mesh is mixed by proportioning
Close uniformly, obtain mixed powder 2；
C, mixed powder 1 and mixed powder 2 are poured into three-dimensional motion mixer always to mix, the rotating speed of described three-dimensional motion mixer is
10-20r/min, incorporation time 25-35min；
D, dispensed using composite film packaging machine, detect sealant and device；
E, product is subjected to outer packing, finished product storage after quality inspection is qualified, you can.
8. the preparation technology with the solid beverage for improving nerve cell function as claimed in claim 7, it is characterised in that institute
The step A-D stated is completed in for 100000 grades of clean areas.
9. the preparation technology with the solid beverage for improving nerve cell function as claimed in claim 8, it is characterised in that institute
The 100000 grades of clean areas stated, specific implementation requirement are：
Suspended particles（>=0.55 μm of particle）≤ 3500000/m3；
（>=5 μm of particles）≤ 20000/m3；
Settling bacteria≤10cfu/ ware * 30min；
Flcating germ≤500cfu/m3；
Rate of ventilation >=15 time/h；
Static pressure difference >=10Pa；
18-26 DEG C of temperature；
Relative humidity 45%-65%；
Illumination 300.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710631276.3A CN107683997A (en) | 2017-07-28 | 2017-07-28 | It is a kind of that there is the solid beverage and its preparation technology for improving nerve cell function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710631276.3A CN107683997A (en) | 2017-07-28 | 2017-07-28 | It is a kind of that there is the solid beverage and its preparation technology for improving nerve cell function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107683997A true CN107683997A (en) | 2018-02-13 |
Family
ID=61153124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710631276.3A Pending CN107683997A (en) | 2017-07-28 | 2017-07-28 | It is a kind of that there is the solid beverage and its preparation technology for improving nerve cell function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107683997A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110558516A (en) * | 2019-09-29 | 2019-12-13 | 乌林奇 | Composition for treating obesity through targeted supplement of BDNF and FTO gene ligands and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754263B2 (en) * | 2003-04-16 | 2010-07-13 | Vdf Futureceuticals, Inc. | Methods for coffee cherry products |
| CN103238897A (en) * | 2013-05-02 | 2013-08-14 | 广州施健生物科技有限公司 | Composite plant solid drink suitable for diabetic patients |
| CN104258241A (en) * | 2014-09-26 | 2015-01-07 | 洛阳华以生物工程有限公司 | Health product for preventing and treating senile dementia |
| CN106174479A (en) * | 2016-07-08 | 2016-12-07 | 北京斯利安药业有限公司 | A kind of geriatric nutrition powder and preparation method thereof |
| CN106261437A (en) * | 2016-08-18 | 2017-01-04 | 娄尤来 | A kind of Germinatus Phragmitis Radix Glycyrrhizae solid beverage and preparation method thereof |
-
2017
- 2017-07-28 CN CN201710631276.3A patent/CN107683997A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7754263B2 (en) * | 2003-04-16 | 2010-07-13 | Vdf Futureceuticals, Inc. | Methods for coffee cherry products |
| CN103238897A (en) * | 2013-05-02 | 2013-08-14 | 广州施健生物科技有限公司 | Composite plant solid drink suitable for diabetic patients |
| CN104258241A (en) * | 2014-09-26 | 2015-01-07 | 洛阳华以生物工程有限公司 | Health product for preventing and treating senile dementia |
| CN106174479A (en) * | 2016-07-08 | 2016-12-07 | 北京斯利安药业有限公司 | A kind of geriatric nutrition powder and preparation method thereof |
| CN106261437A (en) * | 2016-08-18 | 2017-01-04 | 娄尤来 | A kind of Germinatus Phragmitis Radix Glycyrrhizae solid beverage and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| TANIA REYES-IZQUIERDO ET AL: ""Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in", 《BRITISH JOURNAL OF NUTRITION》 * |
| 周秋丽等: "《现代中药基础研究与临床》", 30 June 2012, 天津科技翻译出版公司 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110558516A (en) * | 2019-09-29 | 2019-12-13 | 乌林奇 | Composition for treating obesity through targeted supplement of BDNF and FTO gene ligands and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108783431A (en) | A kind of fruit ferment and preparation method thereof | |
| CN105167072A (en) | Production method of functional Chinese wolfberry fruit enzyme and product thereof | |
| BRPI0615785A2 (en) | cholesterol absorption inhibitor | |
| EP3613425B1 (en) | Plant extract composition promoting collagen growth, reducing wrinkles and enhancing skin and joint elasticity | |
| US20150265527A1 (en) | Method for enhancing collagen secretion and preventing cutaneous aging using chenopodium formosanum extract | |
| KR101701636B1 (en) | Method for health food using linseed and berries and linseed and rice bran | |
| CN113543793A (en) | Preparation method of spirulina extract, and pharmaceutical composition and health functional food containing spirulina extract for improving cognitive ability | |
| KR101763652B1 (en) | Composition for improving study skills | |
| CN107683997A (en) | It is a kind of that there is the solid beverage and its preparation technology for improving nerve cell function | |
| KR20040063680A (en) | Functional vinegar containing diet enzyme, herb medicines and functional materials | |
| KR101429665B1 (en) | Preparation Method of Fermented Products containing ginsenoside and GABA by fermentation technology with lactic acid bacteria from red ginseng and seaweeds | |
| KR101773843B1 (en) | Sweet Jelly Containing Cranberry With Antioxidant Activity And Method for Preparing thereof | |
| CN106805042A (en) | A kind of grape apple beverage of reducing blood lipid and preparation method thereof | |
| CN112293740A (en) | Composition for enhancing immunity and preparation method and application thereof | |
| CN105961975B (en) | A kind of drinks and preparation method thereof containing chlorella growth factor | |
| KR100856567B1 (en) | Method for make of Health Supplement Food containing Wild Ginseng root cultivated powder | |
| CN106804872A (en) | A kind of deep-sea fish oligopeptide albumen powder with human body anti-oxidation function | |
| CN103989720A (en) | Preparation method of compound amino acid suncured ginseng capsule | |
| Shen et al. | Main functional ingredients, nutritional, and medicinal values of common wild edible fungi: a review. | |
| KR20040063695A (en) | Functional feed | |
| CN109771518A (en) | A kind of alimentation composition and its preparation method and application with prevention and improvement Alzheimer disease | |
| Yang et al. | Evaluation of lipid-lowering and immunomodulatory activities of extract oil of Tartary buckwheat fermented by Monascus purpureus in mice | |
| CN107950700A (en) | Tea enzyme beverage and preparation method thereof | |
| CN113785982B (en) | Anti-fatigue and anti-radiation capsule for spaceflight and preparation method thereof | |
| CN108432888A (en) | A kind of novel high-nutrition soybean oil and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180213 |